jason fung glp 1 Hacking The Incretin Hormones. The hormones behind why Ozempic/… | by Dr. The obesity epidemic cannot be

The potential benefits of GLP-1 receptor agonists for lymphedema patients are primarily indirect and related to weight management rather than direct lymphatic effects

55% of patients on combination therapy with 37to 44% of patients reaching risk based goals To view or add a comment, sign in Combination Lipid Lowering therapy should be standard of care in high and very high risk pts with FDC single pills to reduce medication burden

There are ones approved for type 2 diabetes, like Ozempic (semaglutide) and Mounjaro (tirzepatide), as well as ones approved for weight loss, like Wegovy (semaglutide) and Zepbound (tirzepatide)

It is treatable, so ask your provider about testing

But imma need to stock up first real quick